Abstract
OBJECTIVESThe emergence of multidrug-resistant tuberculosis (MDR-TB) is a major challenge for the global control of tuberculosis (TB). The aim of this study was to determine the risk factors associated with MDR-TB in Sudan.METHODSThis case-control study was conducted from May 2017 to February 2019. Patients newly diagnosed with MDR-TB were selected as cases, and controls were selected from TB patients who responded to first-line anti-TB drugs. A questionnaire was designed and used to collect data from study participants. Logistic regression was used to evaluate associations between risk factors and MDR-TB infection. The best multivariate model was selected based on the likelihood ratio test.RESULTSA total of 430 cases and 860 controls were selected for this study. A history of previous TB treatment (adjusted odds ratio [aOR], 54.85; 95% confidence interval [CI], 30.48 to 98.69) was strongly associated with MDR-TB infection. We identified interruption of TB treatment (aOR, 7.62; 95% CI, 3.16 to 18.34), contact with MDR-TB patients (aOR, 5.40; 95% CI, 2.69 to 10.74), lower body weight (aOR, 0.89; 95% CI, 0.87 to 0.91), and water pipe smoking (aOR, 3.23; 95% CI, 1.73 to 6.04) as factors associated with MDR-TB infection.CONCLUSIONSPrevious TB treatment and interruption of TB treatment were found to be the main predictors of MDR-TB. Additionally, this study found that contact with MDR-TB patients and water pipe smoking were associated with MDR-TB infection in Sudan. More efforts are required to decrease the rate of treatment interruption, to strengthen patients’ adherence to treatment, and to reduce contact with MDR-TB patients.
Highlights
Tuberculosis (TB) continues to infect millions of people each year, representing a major health challenge and constituting one of the main causes of death worldwide
TB is high in sub-Saharan Africa, among patients who have a history of previous TB treatment [2]
The analysis indicated that a higher body weight had a negative association with Multidrug-resistant tuberculosis (MDR-TB) infection
Summary
Tuberculosis (TB) continues to infect millions of people each year, representing a major health challenge and constituting one of the main causes of death worldwide. In 2017, it was estimated that 558,000 new cases of MDR-TB occurred worldwide, and that 230,000 deaths were due to infections with MDR-TB [3]. Interrupting treatment with anti-TB medicines in an individual infected with TB allows some bacteria to remain alive, giving them a chance to develop resistance. MDR-TB can either occur due to inadequate treatment or direct contact with a MDR-TB patient [4]. Many studies have identified risk factors associated with MDR-TB, including poor adherence to treatment, improper dosage, a short duration of treatment, and inadequate drugs [7]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
